Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Other financing activities (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Other financing activities for 9 consecutive years, with $2.0 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Other financing activities rose 1169.38% year-over-year to $2.0 million, compared with a TTM value of $2.6 million through Jun 2025, down 4.91%, and an annual FY2025 reading of -$10.6 million, changed N/A over the prior year.
  • Other financing activities was $2.0 million for Q2 2025 at SRx Health Solutions, up from $280000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $3.0 million in Q4 2022 and bottomed at $24000.0 in Q3 2021.
  • Average Other financing activities over 5 years is $785533.3, with a median of $518000.0 recorded in 2024.
  • The sharpest move saw Other financing activities surged 2241.67% in 2022, then crashed 82.32% in 2024.
  • Year by year, Other financing activities stood at $24000.0 in 2021, then soared by 12241.67% to $3.0 million in 2022, then tumbled by 48.21% to $1.5 million in 2023, then plummeted by 94.52% to $84000.0 in 2024, then surged by 2317.86% to $2.0 million in 2025.
  • Business Quant data shows Other financing activities for SRXH at $2.0 million in Q2 2025, $280000.0 in Q1 2025, and $84000.0 in Q3 2024.